Danenberg Noam 4
4 · Wize Pharma, Inc. · Filed Dec 17, 2019
Insider Transaction Report
Form 4
Danenberg Noam
Chief Operating Officer
Transactions
- Other
Future Investment Rights
2019-12-13−31,146→ 94,382 total(indirect: See Footnote)Exercise: $0.27From: 2019-12-13Exp: 2024-12-12→ Common Stock (31,146 underlying) - Conversion
Common Stock
2019-12-13+752,581→ 952,681 total(indirect: See Footnote) - Other
Warrants
2019-12-13+1,505,162→ 1,505,162 total(indirect: See Footnote)Exercise: $0.27Exp: 2024-12-12→ Common Stock (1,505,162 underlying)
Footnotes (4)
- [F1]Outstanding debt converted at $0.27 per share.
- [F2]752,581 shares held by Mobigo Inc. and 200,100 previously held shares directly.
- [F3]Exercisable five days following the public announcement of positive clinical data results for LO2A
- [F4]Securities held by Mobigo Inc.